Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Carlos Jiménez-Romero, Johayra Simithy, Anthony Severdia, Daniel Álvarez, Manuel Grosso, Nicole Spivey, Antonio Arias, Pablo N. Solís, Jibin Li & Ismael J. Hidalgo. (2020) Near infrared (NIR)-spectroscopy and in-vitro dissolution absorption system 2 (IDAS2) can help detect changes in the quality of generic drugs. Drug Development and Industrial Pharmacy 46:1, pages 80-90.
Read now
Read now
Articles from other publishers (4)
Gulam Mustafa, Md Ali Mujtaba, Sabna Kotta, Abdullah Habeeballah, Nabil A. Alhakamy, Hibah M. Aldawsari, Shahid Karim & Shadab Md. 2022. Regulatory Affairs in the Pharmaceutical Industry. Regulatory Affairs in the Pharmaceutical Industry
215
240
.
Francis Micheal, Mohanlal Sayana, Rajendra Prasad & Balamurali M. Motial. (2021) Assessment of Prescribability and Switchability by Using Multiple Bioequivalence Assessment Approaches. Drug Metabolism Letters 14:2, pages 141-151.
Crossref
Crossref
Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, Alain Bousquet-Mélou, Peter Lees, Aude A. Ferran & Pierre-Louis Toutain. (2019) Authors’ Reply to Yu et al.: “Levothyrox® New and Old Formulations: Are They Switchable for Millions of Patients?”. Clinical Pharmacokinetics 59:2, pages 283-285.
Crossref
Crossref
Valeria Belleudi, Francesco Trotta, Simona Vecchi, Laura Amato, Antonio Addis & Marina Davoli. (2018) Studies on drug switchability showed heterogeneity in methodological approaches: a scoping review. Journal of Clinical Epidemiology 101, pages 5-16.
Crossref
Crossref